Serum Institute of India

India recently resumed COVID-19 vaccine supply to the UN-backed COVAX with the government allowing Serum Institute of India (SII)…

Prakash Kumar Singh, Director, Government and Regulatory Affairs, SII, is learnt to have recently communicated to the Union Health…

In addition to these three countries, the SII will also export Covishield to Bangladesh under COVAX, they said

The country had suspended exports of COVID-19 vaccines in April to focus on inoculating its own population following a sudden…

Poonawalla said the company's production of the vaccine could go up to 240 million doses a month from around 220 million now

The company will resume small exports via the global vaccine-sharing platform COVAX this month and raise it substantially by…

As both leaders hint at the intangibles of the alliance, let's hope they make good their promise to both patients as well as…

The Pune-based pharmaceutical company has enhanced the manufacturing capacity of Covishield to more than 20 crore doses per month

India has huge vaccine manufacturiing capabilities but ensuring strict adherence to Good Manufacturing Practices (GMP) will be…

Since there was a shortage of the vaccine, the Modi government changed it to three months, but a two-month gap is ideal,"…